Related Experiment Video
Updated: Jul 12, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Not your usual drug-induced liver injury: Dolutegravir-associated granulomatous hepatitis
Muhammed Vally1,2, Muhammad Ayob1,2, Adam Mahomed1,2
1Division of Medical Gastroenterology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Abstract:
Dolutegravir is an integrase inhibitor in first-line antiretroviral therapy in South Africa. We describe a patient who developed severe drug-induced liver injury on dolutegravir-containing antiretroviral treatment, in whom liver biopsy demonstrated subacute hepatic necrosis, non-necrotising granulomatous inflammation, and bile duct injury: an uncommon histological pattern in dolutegravir-associated hepatotoxicity.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Drug toxicity: Idiosyncratic Reactions
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Drug Toxicity: Risk factors
Hepatic Drug Excretion: Influencing Factors
